Sight Sciences Inc. (NASDAQ: SGHT)
$8.28
+0.4600 ( +5.88% ) 300.4K
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Market Data
Open
$8.28
Previous close
$7.82
Volume
300.4K
Market cap
$413.47M
Day range
$7.22 - $8.35
52 week range
$1.04 - $9.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Apr 04, 2024 |
4 | Insider transactions | 1 | Apr 04, 2024 |
4 | Insider transactions | 1 | Apr 04, 2024 |
10-k | Annual reports | 82 | Mar 13, 2024 |
8-k | 8K-related | 37 | Mar 07, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |